{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T16:27:23Z","timestamp":1777566443512,"version":"3.51.4"},"reference-count":38,"publisher":"Springer Science and Business Media LLC","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"funder":[{"name":"Laboratory of Excellence in Research on Medication and Innovative Therapeutics (LERMIT)","award":["ANR-10-LABX-33"],"award-info":[{"award-number":["ANR-10-LABX-33"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Comput Aided Mol Des"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1007\/s10822-016-9983-3","type":"journal-article","created":{"date-parts":[[2016,10,3]],"date-time":"2016-10-03T13:13:23Z","timestamp":1475500403000},"page":"829-839","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Molecular docking performance evaluated on the D3R Grand Challenge 2015 drug-like ligand datasets"],"prefix":"10.1007","volume":"30","author":[{"given":"Edithe","family":"Selwa","sequence":"first","affiliation":[]},{"given":"Virginie Y.","family":"Martiny","sequence":"additional","affiliation":[]},{"given":"Bogdan I.","family":"Iorga","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2016,10,3]]},"reference":[{"issue":"2","key":"9983_CR1","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1007\/s11912-010-0086-3","volume":"12","author":"JM Holzbeierlein","year":"2010","unstructured":"Holzbeierlein JM, Windsperger A, Vielhauer G (2010) Hsp90: A drug target? Curr Oncol Rep 12(2):95\u2013101. doi:\n                        10.1007\/s11912-010-0086-3","journal-title":"Curr Oncol Rep"},{"issue":"9","key":"9983_CR2","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.2174\/156652412803306657","volume":"12","author":"L Whitesell","year":"2012","unstructured":"Whitesell L, Santagata S, Lin NU (2012) Inhibiting HSP90 to treat cancer: a strategy in evolution. Curr Mol Med 12(9):1108\u20131124. doi:\n                        10.2174\/156652412803306657","journal-title":"Curr Mol Med"},{"issue":"6","key":"9983_CR3","doi-asserted-by":"publisher","first-page":"1381","DOI":"10.1111\/febs.12147","volume":"280","author":"JJ Barrott","year":"2013","unstructured":"Barrott JJ, Haystead TA (2013) Hsp90, an unlikely ally in the war on cancer. FEBS J 280(6):1381\u20131396. doi:\n                        10.1111\/febs.12147","journal-title":"FEBS J"},{"key":"9983_CR4","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1007\/128_2012_356","volume":"328","author":"SE Jackson","year":"2013","unstructured":"Jackson SE (2013) Hsp90: structure and function. Top Curr Chem 328:155\u2013240. doi:\n                        10.1007\/128_2012_356","journal-title":"Top Curr Chem"},{"issue":"3","key":"9983_CR5","doi-asserted-by":"publisher","first-page":"106","DOI":"10.4103\/2319-4170.113230","volume":"36","author":"J Li","year":"2013","unstructured":"Li J, Buchner J (2013) Structure, function and regulation of the Hsp90 machinery. Biomed J 36(3):106\u2013117. doi:\n                        10.4103\/2319-4170.113230","journal-title":"Biomed J"},{"issue":"4","key":"9983_CR6","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1007\/s12253-013-9675-4","volume":"19","author":"JM Patki","year":"2013","unstructured":"Patki JM, Pawar SS (2013) HSP90: chaperone-me-not. Pathol Oncol Res 19(4):631\u2013640. doi:\n                        10.1007\/s12253-013-9675-4","journal-title":"Pathol Oncol Res"},{"issue":"2","key":"9983_CR7","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1016\/j.tibs.2014.12.002","volume":"40","author":"GE Karagoz","year":"2015","unstructured":"Karagoz GE, Rudiger SG (2015) Hsp90 interaction with clients. Trends Biochem Sci 40(2):117\u2013125. doi:\n                        10.1016\/j.tibs.2014.12.002","journal-title":"Trends Biochem Sci"},{"key":"9983_CR8","doi-asserted-by":"publisher","first-page":"100","DOI":"10.3389\/fonc.2015.00100","volume":"5","author":"N Khurana","year":"2015","unstructured":"Khurana N, Bhattacharyya S (2015) Hsp90, the concertmaster: tuning transcription. Front Oncol 5:100. doi:\n                        10.3389\/fonc.2015.00100","journal-title":"Front Oncol"},{"issue":"5","key":"9983_CR9","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1111\/cbdd.12582","volume":"86","author":"HM Kumalo","year":"2015","unstructured":"Kumalo HM, Bhakat S, Soliman ME (2015) Heat\u2013shock protein 90 (Hsp90) as anticancer target for drug discovery: an ample computational perspective. Chem Biol Drug Des 86(5):1131\u20131160. doi:\n                        10.1111\/cbdd.12582","journal-title":"Chem Biol Drug Des"},{"issue":"1","key":"9983_CR10","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.molcel.2015.02.022","volume":"58","author":"MP Mayer","year":"2015","unstructured":"Mayer MP, Le Breton L (2015) Hsp90: breaking the symmetry. Mol Cell 58(1):8\u201320. doi:\n                        10.1016\/j.molcel.2015.02.022","journal-title":"Mol Cell"},{"issue":"4","key":"9983_CR11","doi-asserted-by":"publisher","first-page":"2589","DOI":"10.3390\/biom5042589","volume":"5","author":"R Pennisi","year":"2015","unstructured":"Pennisi R, Ascenzi P, di Masi A (2015) Hsp90: A new player in DNA repair? Biomolecules 5(4):2589\u20132618. doi:\n                        10.3390\/biom5042589","journal-title":"Biomolecules"},{"issue":"8","key":"9983_CR12","doi-asserted-by":"publisher","first-page":"594","DOI":"10.1002\/bip.22835","volume":"105","author":"LH Pearl","year":"2016","unstructured":"Pearl LH (2016) The HSP90 molecular chaperone-an enigmatic ATPase. Biopolymers 105(8):594\u2013607. doi:\n                        10.1002\/bip.22835","journal-title":"Biopolymers"},{"issue":"10","key":"9983_CR13","doi-asserted-by":"publisher","first-page":"2697","DOI":"10.1194\/jlr.M038802","volume":"54","author":"LV Danai","year":"2013","unstructured":"Danai LV, Guilherme A, Guntur KV, Straubhaar J, Nicoloro SM, Czech MP (2013) Map4k4 suppresses Srebp-1 and adipocyte lipogenesis independent of JNK signaling. J Lipid Res 54(10):2697\u20132707. doi:\n                        10.1194\/jlr.M038802","journal-title":"J Lipid Res"},{"issue":"11","key":"9983_CR14","doi-asserted-by":"publisher","first-page":"e1003737","DOI":"10.1371\/journal.ppat.1003737","volume":"9","author":"DA Haas","year":"2013","unstructured":"Haas DA, Bala K, Busche G, Weidner-Glunde M, Santag S, Kati S, Gramolelli S, Damas M, Dittrich-Breiholz O, Kracht M, Ruckert J, Varga Z, Keri G, Schulz TF (2013) The inflammatory kinase MAP4K4 promotes reactivation of Kaposi\u2019s sarcoma herpesvirus and enhances the invasiveness of infected endothelial cells. PLoS Pathog 9(11):e1003737. doi:\n                        10.1371\/journal.ppat.1003737","journal-title":"PLoS Pathog"},{"issue":"4","key":"9983_CR15","doi-asserted-by":"publisher","first-page":"678","DOI":"10.1128\/mcb.00618-12","volume":"33","author":"M Wang","year":"2013","unstructured":"Wang M, Amano SU, Flach RJ, Chawla A, Aouadi M, Czech MP (2013) Identification of Map4k4 as a novel suppressor of skeletal muscle differentiation. Mol Cell Biol 33(4):678\u2013687. doi:\n                        10.1128\/mcb.00618-12","journal-title":"Mol Cell Biol"},{"issue":"11","key":"9983_CR16","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1021\/acsmedchemlett.5b00215","volume":"6","author":"M Ammirati","year":"2015","unstructured":"Ammirati M, Bagley SW, Bhattacharya SK, Buckbinder L, Carlo AA, Conrad R, Cortes C, Dow RL, Dowling MS, El-Kattan A, Ford K, Guimaraes CR, Hepworth D, Jiao W, LaPerle J, Liu S, Londregan A, Loria PM, Mathiowetz AM, Munchhof M, Orr ST, Petersen DN, Price DA, Skoura A, Smith AC, Wang J (2015) Discovery of an in vivo tool to establish proof-of-concept for MAP4K4-based antidiabetic treatment. ACS Med Chem Lett 6(11):1128\u20131133. doi:\n                        10.1021\/acsmedchemlett.5b00215","journal-title":"ACS Med Chem Lett"},{"key":"9983_CR17","doi-asserted-by":"publisher","first-page":"8995","DOI":"10.1038\/ncomms9995","volume":"6","author":"RJ Roth Flach","year":"2015","unstructured":"Roth Flach RJ, Skoura A, Matevossian A, Danai LV, Zheng W, Cortes C, Bhattacharya SK, Aouadi M, Hagan N, Yawe JC, Vangala P, Menendez LG, Cooper MP, Fitzgibbons TP, Buckbinder L, Czech MP (2015) Endothelial protein kinase MAP4K4 promotes vascular inflammation and atherosclerosis. Nat Commun 6:8995. doi:\n                        10.1038\/ncomms9995","journal-title":"Nat Commun"},{"issue":"12","key":"9983_CR18","doi-asserted-by":"publisher","first-page":"2667","DOI":"10.1021\/acschembio.5b00679","volume":"10","author":"AG Schwaid","year":"2015","unstructured":"Schwaid AG, Su C, Loos P, Wu J, Nguyen C, Stone KL, Kanyo J, Geoghegan KF, Bhattacharya SK, Dow RL, Buckbinder L, Carpino PA (2015) MAP4K4 is a threonine kinase that phosphorylates FARP1. ACS Chem Biol 10(12):2667\u20132671. doi:\n                        10.1021\/acschembio.5b00679","journal-title":"ACS Chem Biol"},{"issue":"7544","key":"9983_CR19","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1038\/nature14323","volume":"519","author":"P Vitorino","year":"2015","unstructured":"Vitorino P, Yeung S, Crow A, Bakke J, Smyczek T, West K, McNamara E, Eastham-Anderson J, Gould S, Harris SF, Ndubaku C, Ye W (2015) MAP4K4 regulates integrin-FERM binding to control endothelial cell motility. Nature 519(7544):425\u2013430. doi:\n                        10.1038\/nature14323","journal-title":"Nature"},{"issue":"8","key":"9983_CR20","doi-asserted-by":"publisher","first-page":"11457","DOI":"10.1007\/s13277-016-5022-1","volume":"37","author":"XJ Feng","year":"2016","unstructured":"Feng XJ, Pan Q, Wang SM, Pan YC, Wang Q, Zhang HH, Zhu MH, Zhang SH (2016) MAP4K4 promotes epithelial-mesenchymal transition and metastasis in hepatocellular carcinoma. Tumor Biol 37(8):11457\u201311467. doi:\n                        10.1007\/s13277-016-5022-1","journal-title":"Tumor Biol"},{"key":"9983_CR21","doi-asserted-by":"publisher","first-page":"16221","DOI":"10.1074\/jbc.M116.718932","volume":"291","author":"RJ Roth Flach","year":"2016","unstructured":"Roth Flach RJ, Danai LV, DiStefano MT, Kelly M, Garcia Menendez L, Jurczyk A, Sharma RB, Jung DY, Kim JH, Kim JK, Bortell R, Alonso LC, Czech MP (2016) Protein Kinase Mitogen Activated Protein Kinase Kinase Kinase Kinase 4 (MAP4K4) promotes obesity-induced hyperinsulinemia. J Biol Chem 291:16221\u201316230. doi:\n                        10.1074\/jbc.M116.718932","journal-title":"J Biol Chem"},{"issue":"7","key":"9983_CR22","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/j.tem.2016.04.006","volume":"27","author":"JV Virbasius","year":"2016","unstructured":"Virbasius JV, Czech MP (2016) Map4k4 signaling nodes in metabolic and cardiovascular diseases. Trends Endocrinol Metab 27(7):484\u2013492. doi:\n                        10.1016\/j.tem.2016.04.006","journal-title":"Trends Endocrinol Metab"},{"issue":"24","key":"9983_CR23","doi-asserted-by":"publisher","first-page":"7503","DOI":"10.1016\/j.bmcl.2010.10.010","volume":"20","author":"M Bruncko","year":"2010","unstructured":"Bruncko M, Tahir SK, Song X, Chen J, Ding H, Huth JR, Jin S, Judge RA, Madar DJ, Park CH, Park CM, Petros AM, Tse C, Rosenberg SH, Elmore SW (2010) N-aryl-benzimidazolones as novel small molecule HSP90 inhibitors. Bioorg Med Chem Lett 20(24):7503\u20137506. doi:\n                        10.1016\/j.bmcl.2010.10.010","journal-title":"Bioorg Med Chem Lett"},{"issue":"6","key":"9983_CR24","doi-asserted-by":"publisher","first-page":"963","DOI":"10.1002\/cmdc.200900011","volume":"4","author":"JJ Barker","year":"2009","unstructured":"Barker JJ, Barker O, Boggio R, Chauhan V, Cheng RK, Corden V, Courtney SM, Edwards N, Falque VM, Fusar F, Gardiner M, Hamelin EM, Hesterkamp T, Ichihara O, Jones RS, Mather O, Mercurio C, Minucci S, Montalbetti CA, Muller A, Patel D, Phillips BG, Varasi M, Whittaker M, Winkler D, Yarnold CJ (2009) Fragment-based identification of Hsp90 inhibitors. ChemMedChem 4(6):963\u2013966. doi:\n                        10.1002\/cmdc.200900011","journal-title":"ChemMedChem"},{"issue":"8","key":"9983_CR25","doi-asserted-by":"publisher","first-page":"3484","DOI":"10.1021\/jm500155b","volume":"57","author":"TD Crawford","year":"2014","unstructured":"Crawford TD, Ndubaku CO, Chen H, Boggs JW, Bravo BJ, Delatorre K, Giannetti AM, Gould SE, Harris SF, Magnuson SR, McNamara E, Murray LJ, Nonomiya J, Sambrone A, Schmidt S, Smyczek T, Stanley M, Vitorino P, Wang L, West K, Wu P, Ye W (2014) Discovery of selective 4-amino-pyridopyrimidine inhibitors of MAP4K4 using fragment-based lead identification and optimization. J Med Chem 57(8):3484\u20133493. doi:\n                        10.1021\/jm500155b","journal-title":"J Med Chem"},{"issue":"18","key":"9983_CR26","doi-asserted-by":"publisher","first-page":"4546","DOI":"10.1016\/j.bmcl.2014.07.071","volume":"24","author":"L Wang","year":"2014","unstructured":"Wang L, Stanley M, Boggs JW, Crawford TD, Bravo BJ, Giannetti AM, Harris SF, Magnuson SR, Nonomiya J, Schmidt S, Wu P, Ye W, Gould SE, Murray LJ, Ndubaku CO, Chen H (2014) Fragment-based identification and optimization of a class of potent pyrrolo[2,1-f][1, 2, 4]triazine MAP4K4 inhibitors. Bioorg Med Chem Lett 24(18):4546\u20134552. doi:\n                        10.1016\/j.bmcl.2014.07.071","journal-title":"Bioorg Med Chem Lett"},{"key":"9983_CR27","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13321-015-0056-8","volume":"7","author":"A Gobbi","year":"2015","unstructured":"Gobbi A, Giannetti AM, Chen H, Lee ML (2015) Atom\u2013Atom-Path similarity and Sphere Exclusion clustering: tools for prioritizing fragment hits. J Cheminform 7:11. doi:\n                        10.1186\/s13321-015-0056-8","journal-title":"J Cheminform"},{"issue":"8","key":"9983_CR28","doi-asserted-by":"publisher","first-page":"913","DOI":"10.1021\/acsmedchemlett.5b00174","volume":"6","author":"CO Ndubaku","year":"2015","unstructured":"Ndubaku CO, Crawford TD, Chen H, Boggs JW, Drobnick J, Harris SF, Jesudason R, McNamara E, Nonomiya J, Sambrone A, Schmidt S, Smyczek T, Vitorino P, Wang L, Wu P, Yeung S, Chen J, Chen K, Ding CZ, Wang T, Xu Z, Gould SE, Murray LJ, Ye W (2015) Structure-based design of GNE-495, a potent and selective MAP4K4 inhibitor with efficacy in retinal angiogenesis. ACS Med Chem Lett 6(8):913\u2013918. doi:\n                        10.1021\/acsmedchemlett.5b00174","journal-title":"ACS Med Chem Lett"},{"issue":"1","key":"9983_CR29","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1093\/nar\/28.1.235","volume":"28","author":"HM Berman","year":"2000","unstructured":"Berman HM, Westbrook J, Feng Z, Gilliland G, Bhat TN, Weissig H, Shindyalov IN, Bourne PE (2000) The Protein Data Bank. Nucl Acids Res 28(1):235\u2013242. doi:\n                        10.1093\/nar\/28.1.235","journal-title":"Nucl Acids Res"},{"issue":"3","key":"9983_CR30","doi-asserted-by":"publisher","first-page":"779","DOI":"10.1006\/jmbi.1993.1626","volume":"234","author":"A Sali","year":"1993","unstructured":"Sali A, Blundell TL (1993) Comparative protein modelling by satisfaction of spatial restraints. J Mol Biol 234(3):779\u2013815. doi:\n                        10.1006\/jmbi.1993.1626","journal-title":"J Mol Biol"},{"issue":"4","key":"9983_CR31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1002\/prot.10465","volume":"52","author":"ML Verdonk","year":"2003","unstructured":"Verdonk ML, Cole JC, Hartshorn MJ, Murray CW, Taylor RD (2003) Improved protein\u2013ligand docking using GOLD. Proteins Struct Funct Bioinform 52(4):609\u2013623. doi:\n                        10.1002\/prot.10465","journal-title":"Proteins Struct Funct Bioinform"},{"issue":"2","key":"9983_CR32","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1002\/jcc.21334","volume":"31","author":"O Trott","year":"2010","unstructured":"Trott O, Olson AJ (2010) AutoDock Vina: improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. J Comput Chem 31(2):455\u2013461. doi:\n                        10.1002\/jcc.21334","journal-title":"J Comput Chem"},{"issue":"16","key":"9983_CR33","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","volume":"30","author":"GM Morris","year":"2009","unstructured":"Morris GM, Huey R, Lindstrom W, Sanner MF, Belew RK, Goodsell DS, Olson AJ (2009) AutoDock4 and AutoDockTools4: automated docking with selective receptor flexibility. J Comput Chem 30(16):2785\u20132791. doi:\n                        10.1002\/jcc.21256","journal-title":"J Comput Chem"},{"issue":"5","key":"9983_CR34","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1007\/s10822-011-9526-x","volume":"26","author":"G Surpateanu","year":"2012","unstructured":"Surpateanu G, Iorga BI (2012) Evaluation of docking performance in a blinded virtual screening of fragment-like trypsin inhibitors. J Comput Aided Mol Des 26(5):595\u2013601. doi:\n                        10.1007\/s10822-011-9526-x","journal-title":"J Comput Aided Mol Des"},{"issue":"4","key":"9983_CR35","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1007\/s10822-014-9707-5","volume":"28","author":"C Colas","year":"2014","unstructured":"Colas C, Iorga BI (2014) Virtual screening of the SAMPL4 blinded HIV integrase inhibitors dataset. J Comput Aided Mol Des 28(4):455\u2013462. doi:\n                        10.1007\/s10822-014-9707-5","journal-title":"J Comput Aided Mol Des"},{"issue":"6","key":"9983_CR36","doi-asserted-by":"publisher","first-page":"996","DOI":"10.1021\/acs.jcim.5b00337","volume":"56","author":"VY Martiny","year":"2016","unstructured":"Martiny VY, Martz F, Selwa E, Iorga BI (2016) Blind pose prediction, scoring, and affinity ranking of the CSAR 2014 dataset. J Chem Inf Model 56(6):996\u20131003. doi:\n                        10.1021\/acs.jcim.5b00337","journal-title":"J Chem Inf Model"},{"issue":"D1","key":"9983_CR37","doi-asserted-by":"publisher","first-page":"D1075","DOI":"10.1093\/nar\/gkt978","volume":"42","author":"Y Wang","year":"2014","unstructured":"Wang Y, Suzek T, Zhang J, Wang J, He S, Cheng T, Shoemaker BA, Gindulyte A, Bryant SH (2014) Pubchem bioassay: 2014 update. Nucl Acids Res 42 (D1):D1075\u2013D1082. doi:\n                        10.1093\/nar\/gkt978","journal-title":"Nucl Acids Res"},{"issue":"1","key":"9983_CR38","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/j.1747-0285.2007.00535.x","volume":"70","author":"JR Huth","year":"2007","unstructured":"Huth JR, Park C, Petros AM, Kunzer AR, Wendt MD, Wang X, Lynch CL, Mack JC, Swift KM, Judge RA, Chen J, Richardson PL, Jin S, Tahir SK, Matayoshi ED, Dorwin SA, Ladror US, Severin JM, Walter KA, Bartley DM, Fesik SW, Elmore SW, Hajduk PJ (2007) Discovery and design of novel HSP90 inhibitors using multiple fragment-based design strategies. Chem Biol Drug Des 70(1):1\u201312. doi:\n                        10.1111\/j.1747-0285.2007.00535.x","journal-title":"Chem Biol Drug Des"}],"container-title":["Journal of Computer-Aided Molecular Design"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-016-9983-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10822-016-9983-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10822-016-9983-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2016,10,24]],"date-time":"2016-10-24T18:50:36Z","timestamp":1477335036000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10822-016-9983-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["9983"],"URL":"https:\/\/doi.org\/10.1007\/s10822-016-9983-3","relation":{},"ISSN":["0920-654X","1573-4951"],"issn-type":[{"value":"0920-654X","type":"print"},{"value":"1573-4951","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,9]]}}}